Tetraphase (TTPH) Prices 10.7M IPO at $7/Share
- Wall St slips as dour earnings, chip stocks weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- United Airlines maintains forecast after Q1 results top Wall Street estimates
- Dollar eases, near 5-1/2 month high, on hawkish Fed outlook
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- Barnes & Noble Education (BNED) Enters Definitive Agreement with Immersion (IMMR)
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
Tetraphase Pharmaceuticals (TTPH) IPO Opens, Trades Flat
March 20, 2013 10:15 AM EDTThe IPO for Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) is open for trading. Shares opened at $7.20 after pricing 10,714,286 shares of common stock at a price to the public of $7.00 per share, less underwriting discounts and commissions.
In the IPO, Tetraphase has granted the... More